Funding
← Back to your selection

Janus Henderson Investors

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
3
Confirmed lead rounds
0
1 roles undisclosed
New companies
3
First participation on record · 0 follow-on
Funding in participating rounds
$1.1B
3 disclosed · full round size, not this investor’s share

By stage

Series C+3

By primary sector

Biotech2
Climate tech1

By country

United States2
1

Rounds

3 in this selection
Encoded Therapeutics Inc.

Encoded develops precision gene therapies for neurological disorders, led by ETX101, a gene-regulation therapy for people with SCN1A-positive Dravet syndrome.

$275MSeries F
Participant
FORM ENERGY

Long-duration iron-air batteries designed to store electricity for multi-day grid needs.

$750MSeries G
Participant